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Repeatability of the Six-Minute Walk
Test and Relation to Physical Function
in Survivors of a Critical Illness
Jennifer A. Alison, Patricia Kenny, Madeleine T. King, Sharon McKinley,
Leanne M. Aitken, Gavin D. Leslie, Doug Elliott
Background. The Six-Minute Walk Test (6MWT) is widely used as an outcome
measure in exercise rehabilitation. However, the repeatability of the 6MWT per-
formed at home in survivors of a critical illness has not been evaluated.
Objective. The purpose of this study was to evaluate, in survivors of a critical
illness: (1) the repeatability of the 6MWT performed at home, (2) the effect on
estimates of change in functional exercise capacity if only one 6MWT was performed
at follow-up assessments, and (3) the relationship between the physical functioning
(PF) score of the 36-Item Short-Form Health Survey questionnaire (SF-36) and the 6MWT.
Design. Repeated measures of the 6MWT and SF-36 were obtained.
Methods. Eligible participants had an intensive care unit (ICU) length of stay of
48 hours and were mechanically ventilated for 24 hours. Two 6MWTs and the
SF-36 were conducted in participants’ homes at weeks 1, 8, and 26 after hospital
discharge.
Results. One hundred seventy-three participants completed the study. The partic-
ipants had a mean age of 57 years (SD16), a mean Acute Physiology and Chronic
Health Evaluation II (APACHE II) score on admission of 19 (SD10), a mean ICU
length of stay of 9 days (SD8), and a mean mechanical ventilation time of 140 hours
(SD137). Of the 173 participants, 110 performed two 6MWTs at weeks 1, 8, and 26.
There were significant mean increases in 6-minute walk distance in the second test
of 15 m (P.0001) at week 1, 13 m (P.0001) at week 8, and 9 m (P.04) at week
26. If only one 6MWT was performed at weeks 8 and 26, the estimate of change in
6-minute walk distance from week 1 was 19 m less (P.001) at both weeks 8 and 26.
There was a moderate to strong correlation between SF-36 PF score and 6-minute
walk distance at each assessment (week 1: r.62, P.001; week 8: r.55, P.001;
and week 26: r.47, P.001).
Limitations. Some study participants were unable to perform a second 6MWT,
and these participants may have differed in important aspects of function compared
with those individuals who completed two 6MWTs.
Conclusions. In survivors of a critical illness, the 6MWT in the home environ-
ment should be performed twice at each assessment to give an accurate reflection of
change in exercise capacity over time. The SF-36 PF score was a strong indicator of
6-minute walk distance in early recovery from a critical illness.
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The Six-Minute Walk Test(6MWT) is widely used as anoutcome measure in exercise
rehabilitation. Previous research has
shown a 7% to 14% increase in dis-
tance walked in a second 6MWT in
participants with chronic obstruc-
tive pulmonary disease1–3 and an
increase of approximately 8% in
older people who were healthy.4
Two 6MWTs, therefore, are recom-
mended at baseline assessment.5
However, minimal information is
available on the 6MWT in survivors
of a critical illness. First, repeatability
of the 6MWT performed at home in
survivors of a critical illness has not
been evaluated. Second, although it
is recommended that two 6MWTs be
performed at initial assessment5 to
account for a learning effect, it is
unknown whether it is necessary to
perform two 6MWTs at follow-up
assessments and whether perform-
ing only one 6MWT at follow-up
assessment would affect the report-
ing of changes in 6MWT distance in
this patient population. Third, the
relationship between the 6MWT, a
quantitative measure of functional
exercise capacity, and the patient
report of physical function in daily
life using the physical functioning
(PF) score of the 36-Item Short-Form
Health Survey questionnaire (SF-36)
has not been evaluated during the
period of recovery from a critical ill-
ness. A strong relationship between
SF-36 PF and 6MWT scores would
enhance the value of the PF score in
reflecting functional exercise capac-
ity in this population, and may pro-
vide a proxy measure in circum-
stances where staff is not available to
conduct a 6MWT. Track configura-
tion has been shown to affect the
distance walked in the 6MWT.2 How-
ever, the effect of variations in track
configuration and environment on
distance walked when the 6MWT is
performed at home is unknown.
The primary aims of the study were
to evaluate, in survivors of a critical
illness: (1) the repeatability of the
6MWT performed at home, (2) the
effect on estimates of change in func-
tional exercise capacity in the longer
term if only one 6MWT was per-
formed at follow-up assessments,
and (3) the relationship between the
SF-36 PF score and the 6MWT at
weeks 1, 8, and 26 following hospital
discharge. A further aim was to eval-
uate the effect of 6MWT track on
walk distance.
Method
This article reports a secondary anal-
ysis of data from a multicenter ran-
domized controlled trial designed to
test the effects of an 8-week, home-
based rehabilitation program com-
pared with usual care on health-
related quality of life and physical
functioning for individuals who sur-
vived a critical illness. The study
methods have been published previ-
ously.6 Briefly, eligible patients had
an ICU length of stay of 48 hours
and were mechanically ventilated for
24 hours. Blinded assessments of
outcome measures of exercise
capacity using the 6MWT5 and of
physical functioning using the SF-36
(version 2)7 were conducted by
trained assessors in participants’
homes at weeks 1, 8, and 26 after
hospital discharge. Relevant institu-
tional review board approvals were
obtained prior to study commence-
ment, and all participants provided
informed consent. A safety protocol
was used to support assessors during
home visits.6
For the 6MWT, a flat track was
marked out in each participant’s
home or local environment. A
detailed record of the track was
kept, including the track distance
and type (circuit or shuttle), to
ensure an identical track was used
for subsequent tests. Two 6MWTs
(test 1 and test 2) were performed at
each time point, with a 30-minute
rest period between tests. Standard-
ized instructions and encouragement
were used based on the guidelines
for the 6MWT5 and detailed in the
Pulmonary Rehabilitation Toolkit.8
During the 6MWT, participants were
directly observed by the assessor.
Pulse rate and oxygen saturation
were monitored continuously via a
portable pulse oximeter (PalmSAT
2500 Digital Pulse Oximeter, Nonin
Medical Inc, Plymouth, Minnesota)
and exertion levels were assessed
using the Borg Perceived Exertion
Scale.9
Initial study findings have been pub-
lished previously.10 No significant
effect of the intervention on physical
functioning or 6-minute walk dis-
tance was demonstrated compared
with changes over time during
recovery in the usual care group.
Therefore, data from both groups
were pooled for further analyses.
Data Analysis
Repeatability of the 6MWT was
assessed at each time point (weeks 1,
8, and 26) using data from respon-
dents who completed two 6MWTs at
all time points. The paired t test was
used to examine whether the mean
difference between the first and sec-
ond 6MWTs was significantly differ-
ent from zero at each time point. The
individual test variability was exam-
ined using plots of individual test dif-
ference against the individual test
average distance and limits of agree-
ment (twice the standard deviation
of the difference between test 1 and
test 2).11
To evaluate whether it was neces-
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follow-up assessments to ensure the
accurate reporting of change in
6-minute walk distance at weeks 8
and 26, the longer walk distance of
the two 6MWTs at week 1 was com-
pared with: (1) the longer of the two
6-minute walk distances at week 8
and week 26 and (2) the first
6-minute walk distance at week 8
and week 26. This analysis used the
mean change at follow-up and 95%
confidence intervals (95% CIs).
The analysis to determine whether
the SF-36 PF score was reflective of
exercise capacity measured by the
6MWT had several aspects. First, the
correlation between the longer
6-minute walk distance and the SF-36
PF score was assessed at weeks 1, 8,
and 26 using the Pearson correlation
coefficient. Second, the variance in
6-minute walk distance explained by
the SF-36 PF score was assessed at
week 1 using multiple regression. A
2-stage analysis was performed
where the effect of patient charac-
teristics potentially associated with
exercise capacity and physical func-
tioning (age and sex), as well as
indicators of illness severity (Acute
Physiology and Chronic Health Eval-
uation II [APACHE II] score and days
in hospital), were included as cova-
riates in the regression analysis, with
6MWT as the dependent variable.
The model also was adjusted for trial
randomization group to ensure the
secondary analysis was not affected.
The analysis then was repeated with
SF-36 PF score added to the model as
an explanatory variable. The differ-
ence in the R2 between the 2 models
provided an estimate of the variance
in 6-minute walk distance explained
by the SF-36 PF score. The third
aspect of the analysis investigated
which items within the SF-36 PF
score were more closely related to
the 6MWT. For this analysis, the
mean and 95% CI of the 6MWT were
plotted against the individual SF-36
PF item responses at week 1.
The impact of track characteristics
on the 6-minute walk distance was
assessed at week 1 using multiple
regression analysis, with 6-minute
walk distance as the dependent vari-
able and track characteristics of
length (circular or straight, indoor or
outdoor) as explanatory variables.
This analysis was adjusted for partic-
ipant characteristics of age, sex,
APACHE II score, and days in
hospital.
Results
One hundred seventy-nine study par-
ticipants completed at least one
6MWT; of this sample, 173 partici-
pants had complete data for the
6MWT and the SF-36 PF at week 1
and were included in the analyses.
Participant characteristics are pre-
sented in Table 1. On average, the
sample had low physical function-
ing, with a mean SF-36 PF score of 37
(95% CI33–41), and a low exercise
capacity, with a mean 6-minute walk
distance of 313 m (95% CI293–
333) at week 1.
Repeatability of the 6MWT
At each assessment time point, sev-
eral participants declined to perform
a second 6MWT (14 of 176 partici-
pants at week 1, 7 of 147 partici-
pants at week 8, and 15 of 143 par-
ticipants at week 26). Reasons given
for declining to repeat the 6MWT
included exhaustion or fatigue,
despite the 30-minute rest period.
For the 110 participants who com-
pleted two 6MWTs at each time
point, the 6-minute walk distance,
on average, was significantly longer
at the second 6MWT (weeks 1 and 8,
P.001; week 26, P.04) (Tab. 2).
Individual mean 6MWT distance and
differences between the first and
second tests at weeks 1, 8, and 26
and the limits of agreement are pre-
sented in Figure 1. Although the
mean differences were relatively
small, the distribution of individual
differences indicated considerable
variability, with a majority of partic-
ipants performing a longer 6-minute
walk distance in the second test, as
indicated by the points above zero in
Figure 1. The limits of agreement were
71, 60, and 92 m at weeks 1, 8,
and 26, respectively. The mean per-
cent difference when test 2 was com-
pared with test 1 showed an increase
of 5% (SD13%), 3% (SD8%), and
2% (SD12%) at weeks 1, 8, and 26,
respectively (Tab. 2).
Effect of Performing Only One
6MWT at Follow-up (Weeks 8
and 26) on Estimate of Change
Over Time
The calculated improvement in
6-minute walk distance was approx-
Table 1.
Characteristics of Participants (N173)
Measure Values
Age (y) 57 (16)
Sex, female/male 40%/60%
APACHE II score 19 (10)
Ventilation (h) 140 (137)
ICU LOS (d) 9 (8)
Hospital LOS (d) 24 (19)
6MWT (m) 313 (132)
SF-36 PF score 37 (26)
a All values are presented as mean (SD) unless otherwise indicated. APACHE IIAcute Physiology and
Chronic Health Evaluation II, ICUintensive care unit, LOSlength of stay, 6MWTSix-Minute Walk
Test, SF-36 PF36-Item Short-Form Health Survey physical functioning scale.
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imately 95 m at week 8 and 122 m at
week 26, when the longer distance
of the two 6MWTs at each time point
was used. When the first 6MWT at
weeks 8 and 26 was used, the calcu-
lated improvement in 6-minute walk
distance was 19 m less (P.001) at
both weeks 8 and 26 (Tab. 2).
Relationship Between 6MWT
Distance and SF-36 PF Score
All participants who completed at
least one 6MWT and the SF-36 PF
domain items at week 1 were
included in the analysis of the rela-
tionship between 6-minute walk dis-
tance and SF-36 PF score. The
6-minute walk distance showed a
moderate to strong, significant corre-
lation with the SF-36 PF score (week
1: r.62, P.001; week 8: r.55,
P.001; and week 26: r.47,
P.001).
At week 1, the SF-36 PF score was
significantly associated with
6-minute walk distance and
explained a further 26% of the vari-
ance in 6-minute walk distance
beyond that explained by covariates,
as indicated by the differences in R2
between models 1 and 2 in Table 3.
Figure 2 illustrates the relationship
between individual items within the
SF-36 PF score and the 6-minute walk
distance at week 1. The responses
(“not limited,” “limited a little,” and
“limited a lot”) to items “climbing
one flight of stairs” and “walking 100
m” were most able to differentiate
6-minute walk distance. For the item
“climbing one flight of stairs,” the
mean distance walked for those
reporting:
1. “limited a lot” (n50) was 216 m
(95% CI187–245)
2. “limited a little” (n75) was
318 m (95% CI293–343)
3. “not limited” (n49) was 403 m
(95% CI365–439).
The mean difference between sub-
groups 1 and 2 was 102 m (95%
CI64–140) (P.0001) and
between subgroups 2 and 3 was
85 m (95% CI42–128) (P.0001).
For the item “walking 100 m,” the
mean distance walked for those
reporting:
1. “limited a lot” (n37) was 189 m
(95% CI157–222)
2. “limited a little” (n62) was
302 m (95% CI274–329)
3. “not limited” (n75) was 383 m
(95% CI357–410).
The mean difference between sub-
groups 1 and 2 was 113 m (95%
CI70–154) (P.0001) and
between subgroups 2 and 3 was
81 m (95% CI44–120) (P.0001).
Effect of Track Characteristics on
6MWT Distance
Track characteristics information
was available for 108 participants.
The mean track length was 23 m
(SD20, median16, range4–130
m). The majority of tracks were out-
side (80%) rather than inside and
straight (66%) rather than circular.
Using multiple regression analysis
and adjusting for age, sex, APACHE II
score, and days in hospital, track
length was significantly associated
with 6-minute walk distance at week
1 (Tab. 4). For each additional meter
of track length, the 6-minute walk
distance increased, on average, by
3 m.
Discussion
The main findings were that a small
but consistent and significant aver-
age increase was observed in the sec-
ond 6MWT distance at each assess-
ment time point, that the reported
change in 6MWT distance at weeks 8
Table 2.
Repeatability of Six-Minute Walk Test (6MWT) Distance (Difference Between Test 1 and Test 2) and Impact of Using 1 or 2






































1 322 (109) 337 (116) 15 (9–22) 5 (13) 0.67
8 419 (126) 432 (135) 13 (7–19) 3 (8) 0.69 95 (79–111) 76 (60–91) 19 (15–23)
26 447 (137) 456 (142) 9 (0.3–18) 2 (12) 0.55 122 (102–143) 103 (83–124) 19 (12–26)
a 6MWT results in meters. 95% CI95% confidence interval; Longerthe longer 6MWT distance of the 2 tests performed at that time point; Firstthe first
6MWT performed at the assessment time point.
b % Differencetest 2  test 1 as percentage of test 1.
c Proportion of participants who walked farther in test 2 than in test 1.
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Figure 1.
Scatter plots (Bland-Altman) of the mean Six-Minute Walk Test (6MWT) score (x-axis) plotted against the difference between 6MWT
1 and 6MWT 2 (y-axis) at week 1 (A), week 8 (B), and week 26 (C). The unbroken line represents mean difference, and broken lines
represent limits of agreement.
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and 26 was greater when the longer
of the two 6MWT distances at these
time points was used for analysis
rather than the first 6MWT distance,
and that the 6MWT distance was
reflective of self-reported limitations
to the SF-36 PF domain items of
“climbing a flight of stairs” and
“walking 100 m.”
Performing a second 6MWT in par-
ticipants who survived a critical ill-
ness resulted in a significant average
increase in walk distance at all assess-
ment time points. The increase in
walk distance when a second 6MWT
was performed was similar to the
findings for other patient cohorts,
particularly those with chronic lung
disease1,2,12 and heart disease13; how-
ever, this is the first study that
Table 3.
Six-Minute Walk Test at Week 1: Regression Models With and Without 36-Item Short-Form Health Survey (SF-36) Physical
Functioning (PF) Score (N173)a
Parameter
Model 1 Model 2
Estimate SE P Estimate SE P
Intercept 404.35 25.71 .0001 364.33 21.81 .0001
SF-36 PF scoreb 2.81 0.32 .0001
Ageb 2.33 0.60 .0001 1.64 0.50 .001
Female 49.22 19.05 .010 13.58 16.31 .41
APACHE II score 1.08 0.97 .27 0.54 0.80 .50
Days in hospital 1.45 0.50 .004 0.72 0.42 .09
Control group 31.72 18.40 .09 20.19 15.31 .19
R2 0.18 0.44
a SEstandard error of the measurement, APACHE IIAcute Physiology and Chronic Health Evaluation II.
b Centered at 40 for SF-36 PF score and at 57 years for age.
Figure 2.
Week 1 36-Item Short-Form Health Survey (SF-36) physical functioning domain items (x-axis) and 6-minute walk distance (6MWD)
(y-axis). Error bars are 95% confidence intervals for 6MWD.
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assessed repeatability of the 6MWT
in people who survived a critical ill-
ness. This cohort may differ from
cohorts with chronic respiratory or
cardiac diseases due to younger
mean age and potential for full recov-
ery after a critical illness. The limits
of agreement between test 1 and test
2 were similar to those reported in
people with chronic obstructive pul-
monary disease,14 demonstrating the
inherent within-participant variabil-
ity in the 6MWT results. Although
the majority of the cohort walked
farther on the second 6MWT at each
time point, most likely due to a famil-
iarization or learning effect, a sub-
stantial minority walked a shorter
distance at the second test (Fig. 1).
The reason for this variability is
unclear, but it has been reported in
other cohorts.14 Some contributing
factors may have been lack of moti-
vation, fatigue, and psychological
issues.
The guidelines for the 6MWT5 rec-
ommend that a practice walk test
(equivalent to test 1 in our study)
should be performed in people naive
to the test. Therefore, two 6MWTs
should be performed at initial assess-
ment. However, there are no recom-
mendations for whether 2 tests
should be performed at follow-up
assessments for the estimate of
group change in intervention
research. Despite the smaller mean
difference in distance walked in a
second 6MWT at week 8 and week
26 compared with the difference at
week 1, the difference that persisted
had a significant impact on the esti-
mate of change in 6-minute walk dis-
tance over time. If only one 6MWT
had been performed at week 8 and
week 26, the reported change in
6-minute walk distance (compared
with week 1) would have been
approximately 19 m less at week 8
and week 26 than if the longer of
two 6MWT distances was used.
Thus, the change in 6-minute walk
distance during recovery from a crit-
ical illness would have been under-
estimated. This underestimation
could potentially represent a sub-
stantial proportion of the effect of an
intervention and result in concluding
that an effective intervention was
ineffective, especially if effectiveness
was based on reaching a minimum
clinically important difference in
6MWT distance, such as 35 m, as has
been reported for people with
chronic obstructive pulmonary dis-
ease.15 Our findings suggest that for
research evaluating the effects of an
intervention over time, it is impor-
tant to perform two 6MWTs at each
subsequent assessment and to use
the longer test distance for analysis
in reporting change in 6-minute walk
distance.
A novel aspect of this study was that
the 6MWTs were performed at par-
ticipants’ homes or in their local
environment. This home environ-
ment meant that walking tracks for
the 6MWT differed among partici-
pants. For example, some indoor
tracks were straight “shuttle” tracks
along corridors and others were cir-
cular tracks through rooms, and
some outdoor tracks were straight
shuttle tracks along flat pavements
and others were circular tracks in flat
parks. Within-participant variability
was controlled by duplicating the
track used for each assessment.
When examining the effect of differ-
ent track types, the main finding was
that only track length affected the
6-minute walk distance, with longer
tracks resulting in greater distance
walked. The impact of slowing down
to turn more frequently on shorter
tracks may explain this finding.5 Our
findings differed from those of a
study of people with severe chronic
obstructive pulmonary disease,2
where straight track length had no
effect on walk distance and a circular
track resulted in greater 6-minute
walk distance than a straight shuttle
track. However, those findings could
conversely support our finding that
track length affected walk distance,
as, by its nature, a circular track is
longer than any straight track.
The SF-36 PF score correlated signif-
icantly with 6-minute walk distance
at each time point (strongest at week
1). Similar positive correlations
between self-reported physical func-
tion and 6-minute walk distance have
previously been reported in other
cohorts.16,17 The week 1 SF-36 PF
score was a significant predictor of
6-minute walk distance, adding 26%
to the variance in 6-minute walk dis-
Table 4.
Regression Model to Investigate the Effect of Track Type (Circular or Straight, Indoor
or Outdoor) and Track Length on the Six-Minute Walk Test at Week 1 (n108)a
Parameter Estimate SE P
Intercept 315.36 31.88 .0001
Circular track 19.23 27.47 .49
Inside track 3.38 24.88 .89
Track length 2.96 0.55 .0001
Ageb 2.93 0.64 .0001
Female 42.01 21.78 .06
APACHE II score 0.05 0.92 .96
Days in hospital 1.63 0.62 .01
R2 0.48
a SEstandard error of the measurement, APACHE IIAcute Physiology and Chronic Health Evaluation II.
b Age centered at 57 years.
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tance explained by other variables
(age, sex, APACHE II score, and days
in hospital). The closer relationship
between the SF-36 PF score and
6-minute walk distance at week 1
compared with weeks 8 and 26 was
likely due to the greater limitation in
walk distance and physical function-
ing at this time point. At subsequent
time points, recovery from a critical
illness may have resulted in a ceiling
effect in scoring of the SF-36 and the
6MWT. Both factors would reduce
the strength of the relationship
between SF-36 PF score and
6-minute walk distance. An interest-
ing finding was that the SF-36 PF
domain items of “walking one flight
of stairs” and “walking 100 m” were
able to distinguish clear differences
in 6-minute walk distance at week 1.
This may be a useful finding, as it
suggests that these items may act as
a surrogate for the 6MWT at this
early stage of recovery from a critical
illness.
Limitations
A limitation of the study was that
some study participants were unable
to perform a second 6MWT, and
these participants may have differed
in important aspects of function
from those individuals who com-
pleted two 6MWTs.
Clinical Importance
Evidence from this study reinforces
the need to perform two 6MWTs for
home assessment of functional exer-
cise capacity for intervention studies
in people recovering from a critical
illness. The use of a consistent track
for all assessments of an individual
should help to minimize the risk of
measurement error. A longer track
length positively influenced distance
walked.
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